Table 3.
Major Steps | Major Challenge |
---|---|
Biomarker Discovery |
|
Pre-validation |
|
Development | High costs of or inaccessibility to isotope labeled analogues for accurate metabolite quantitation using mass spectrometry. |
Validation | Limited access to large and independent sample cohorts. |
Commercialization |
|